iSpecimen (ISPC) Competitors $1.02 +0.02 (+2.00%) Closing price 03:45 PM EasternExtended Trading$1.00 -0.02 (-1.86%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ISPC vs. ANTE, CDTG, BIYA, LDWY, BIAF, QH, LIFW, IDW, GMHS, and ULYShould you be buying iSpecimen stock or one of its competitors? The main competitors of iSpecimen include AirMedia Group (ANTE), CDT Environmental Technology Investment (CDTG), Baiya International Group (BIYA), Lendway (LDWY), bioAffinity Technologies (BIAF), Quhuo (QH), MSP Recovery (LIFW), IDW Media (IDW), Gamehaus (GMHS), and Urgent.ly (ULY). These companies are all part of the "business services" industry. iSpecimen vs. Its Competitors AirMedia Group CDT Environmental Technology Investment Baiya International Group Lendway bioAffinity Technologies Quhuo MSP Recovery IDW Media Gamehaus Urgent.ly AirMedia Group (NASDAQ:ANTE) and iSpecimen (NASDAQ:ISPC) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership and valuation. Which has more risk & volatility, ANTE or ISPC? AirMedia Group has a beta of 1.49, meaning that its share price is 49% more volatile than the S&P 500. Comparatively, iSpecimen has a beta of 1.61, meaning that its share price is 61% more volatile than the S&P 500. Does the media prefer ANTE or ISPC? In the previous week, iSpecimen had 1 more articles in the media than AirMedia Group. MarketBeat recorded 2 mentions for iSpecimen and 1 mentions for AirMedia Group. iSpecimen's average media sentiment score of -0.24 beat AirMedia Group's score of -0.71 indicating that iSpecimen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AirMedia Group 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative iSpecimen 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is ANTE or ISPC more profitable? AirMedia Group has a net margin of 0.00% compared to iSpecimen's net margin of -139.63%. AirMedia Group's return on equity of 0.00% beat iSpecimen's return on equity.Company Net Margins Return on Equity Return on Assets AirMedia GroupN/A N/A N/A iSpecimen -139.63%-285.20%-114.37% Do insiders and institutionals believe in ANTE or ISPC? 1.0% of AirMedia Group shares are held by institutional investors. Comparatively, 13.6% of iSpecimen shares are held by institutional investors. 7.5% of AirMedia Group shares are held by insiders. Comparatively, 12.2% of iSpecimen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has preferable earnings and valuation, ANTE or ISPC? iSpecimen has higher revenue and earnings than AirMedia Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAirMedia Group$340K27.44-$13.65MN/AN/AiSpecimen$9.29M0.27-$12.50M-$12.89-0.08 SummaryiSpecimen beats AirMedia Group on 7 of the 11 factors compared between the two stocks. Get iSpecimen News Delivered to You Automatically Sign up to receive the latest news and ratings for ISPC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ISPC vs. The Competition Export to ExcelMetriciSpecimenMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.50M$7.29B$5.54B$8.95BDividend YieldN/A2.78%5.38%4.08%P/E Ratio-0.0827.9427.4020.04Price / Sales0.2732.39419.46118.60Price / CashN/A22.0836.6357.47Price / Book0.526.698.085.67Net Income-$12.50M$233.06M$3.16B$248.47M7 Day Performance6.92%2.20%2.12%2.90%1 Month Performance-20.00%4.93%4.43%5.75%1 Year Performance277.08%35.84%35.62%21.36% iSpecimen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ISPCiSpecimen0.9174 of 5 stars$1.02+2.0%N/A+239.2%$2.50M$9.29M-0.0860News CoverageANTEAirMedia GroupN/A$0.63-2.3%N/A-38.1%$9.24M$340K0.0070News CoverageCDTGCDT Environmental Technology InvestmentN/A$0.70-5.4%N/A-81.6%$9.12M$29.76M0.00107Gap UpBIYABaiya International GroupN/A$0.73+3.5%N/AN/A$8.88M$12.81M0.0024News CoverageGap DownLDWYLendwayN/A$5.03+3.5%N/A+12.8%$8.60M$37.77M-2.0430Positive NewsGap DownBIAFbioAffinity Technologies1.9057 of 5 stars$0.29-3.0%$6.00+1,989.1%-86.6%$8.42M$9.36M-0.4010Gap DownQHQuhuoN/A$1.20-7.7%N/A+204.8%$8.02M$417.42M0.00680Positive NewsGap DownLIFWMSP RecoveryN/A$1.21-4.0%N/A-88.3%$7.94M$10.73M-0.013Positive NewsIDWIDW MediaN/A$0.55-8.3%N/A+84.9%$7.47M$30.84M-1.5780Gap DownGMHSGamehausN/A$1.62-0.3%N/AN/A$7.37M$145.24M0.00N/APositive NewsGap DownULYUrgent.ly2.1953 of 5 stars$6.40+13.7%$12.00+87.5%-62.3%$7.01M$134.09M-0.20753News CoverageAnalyst Forecast Related Companies and Tools Related Companies ANTE Competitors CDTG Competitors BIYA Competitors LDWY Competitors BIAF Competitors QH Competitors LIFW Competitors IDW Competitors GMHS Competitors ULY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ISPC) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iSpecimen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iSpecimen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
